Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue (Q47629951)

4 February 2018

title

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue (English)

1 reference

4 February 2018

author name string

Brehmer B

series ordinal

1

1 reference

4 February 2018

Biesterfeld S

series ordinal

2

1 reference

4 February 2018

Jakse G

series ordinal

3

1 reference

4 February 2018

publication date

1 January 2003

1 reference

4 February 2018

Prostate Cancer and Prostatic Diseases

published in

1 reference

4 February 2018

volume

6

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

217-222

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500657

exact match

0 references

cites work

Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Metalloproteinases in endochondral bone formation: appearance of tissue inhibitor-resistant metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Degradation of matrix proteins in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Tumor Cell Invasion Inhibited by TIMP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Pathological characteristics and prognosis of nonpalpable and palpable prostate cancers with a Hybritech prostate specific antigen of 4 to 10 ng./ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Matrix metalloproteinases: a multifunctional group of molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Expression of matrix metalloproteinase (gelatinase) in T1 adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

An Abbreviated Standard Procedure for Accurate Tumor Volume Estimation in Prostate Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Tissue inhibitors of metalloproteinases: role in tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Radical Prostatectomy for Impalpable Prostate Cancer: The Johns Hopkins Experience With Tumors Found on Transurethral Resection (Stages T1a and T1b) and on Needle Biopsy (Stage T1c)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500657

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500657

1 reference

4 February 2018

PubMed ID

12970724

1 reference

4 February 2018